These are the stocks posting the largest moves before the bell.Market Insiderread more
"The Champagne should probably be kept on ice, at least until the two presidents put pen to paper," said state-owned media China Daily.Traderead more
China wants to have another round of talks with the U.S. before signing phase one of a trade deal, a source tells CNBC's Kayla Tausche.Marketsread more
U.S. stock index futures turned lower after China said it needed to have further discussions before it would sign off on the so-called phase one trade deal President Trump...US Marketsread more
Analysts say the partial U.S.-China trade deal doesn't touch on thorny issues plaguing both sides, and warn talks could break down again.World Economyread more
U.S. stock futures turn lower after word that China wants more talks before signing the "phase one" trade deal.Marketsread more
Economists polled by Reuters had expected Chinese exports denominated in the U.S. dollar to fall by 3% and imports to decline by 5.2% in September, compared to a year ago.China Economyread more
Economists Abhijit Banerjee, Esther Duflo and Michael Kremer won the 2019 Nobel Economics Prize for their work in fighting global poverty, the Royal Swedish Academy of...World Newsread more
Boeing's board removed CEO Dennis Muilenburg as chairman amid the fall out of two 737 Max crashes that killed 346 people.Aerospace & Defenseread more
The U.K. and EU are gearing up for what could be the busiest week in British politics since June 2016.Europe Politicsread more
The U.S. had plans to hike duties on at least $250 billion in Chinese goods to 30% from 25% on Tuesday. Despite the partial trade deal, some banks on Sunday wrote that tariff...Marketsread more
Intermountain Healthcare made a splash in January when it said it and other major hospital systems, fed up with drug shortages and skyrocketing prices, planned to manufacture their own generic medicines.
Now it has a plan for how it's going to do it. The Salt Lake City-based hospital system is teaming with the Mayo Clinic, HCA Healthcare and four others to form a nonprofit company called Civica Rx. The seven organizations, the company said in a statement Thursday, represent about 500 U.S. hospitals.
The initial focus will be a group of 14 generic drugs that are administered to patients in the hospital. The consortium wouldn't name which they are, but said its first goal is to stabilize supply of essential generic medicines, and that it expects to have its first products on the market as early as next year. Civica Rx will be an Food and Drug Administration-approved manufacturer and will either directly make the drugs itself, or will contract the work out, the company said.
Civica also named a chief executive: Martin Van Trieste, former chief quality officer for biotech giant Amgen.
"We are creating a public asset with a mission to ensure that essential generic medications are accessible and affordable," Van Trieste said in the statement. "This will improve the situation for patients by bringing much needed competition to the generic drug market."
Though the generic drug system is designed to create low-cost versions of branded medicines, lack of competition and other factors have led to continued shortages of certain products, or skyrocketing prices.
Such was the case for Daraprim, the decades-old anti-parasitic drug acquired by Martin Shkreli, who raised the price by 5,000 percent overnight. Or a number of drugs acquired by Valeant Pharmaceuticals, which then boosted prices. The Cleveland Clinic said two heart drugs alone, acquired by Valeant, cost it more than $5 million a year. (Valeant is now know as Bausch Health.)
Without competition, hospitals were left without other options. Now they plan to create their own.
The four other organizations that will govern the nonprofit company are Catholic Health Initiatives, Providence St. Joseph Health, SSM Health and Trinity Health. The U.S. Department of Veterans Affairs, the company said, "will also work in consultation with Civica Rx to address its particular needs."
The Laura and John Arnold Foundation, which has focused on combating high drug prices and other health costs, along with the Peterson Center on Healthcare and the Gary and Mary West Foundation, also focused on affordable health care, will also govern the new company.